English
Senores Pharmaceuticals Q4 Results
- BSE: 544319
- NSE: SENORES
- ISIN: INE0RB801010
- Sector: Biotechnology & Drugs
BSE
799
-3.75 (-0.47%)
-3.75 (-0.47%)Volume4.17 K
Updated: Fri 16 Jan, 2026 | 12:32:51
NSE
803.50
0.35 (0.04%)
0.35 (0.04%)Volume93.28 K
Updated: Fri 16 Jan, 2026 | 12:21:16
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 25
Note: Comparison is on QoQ basis
Quarterly - Senores Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp |
|---|---|---|---|
| Total Operating Expense | 100.00 | 81.54 | 22.64% |
| Depreciation/ Amortization | 5.23 | 4.20 | 24.52% |
| Operating Income | 14.21 | 21.48 | -33.85% |
| Net Income | 17.83 | 17.17 | 3.84% |
| Other Operating Expenses Total | 22.68 | 17.63 | 28.64% |
| Net Income Before Taxes | 20.68 | 20.48 | 0.98% |
| Total Revenue | 114.21 | 103.02 | 10.86% |
| Selling/ General/ Admin Expenses Total | 14.64 | 19.01 | -22.99% |
| Diluted Normalized EPS | 3.98 | 5.04 | -21.06% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.